Tabula Rasa HealthCare Stock Price, News & Analysis (NASDAQ:TRHC)

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) released its quarterly earnings data on Thursday, August, 8th. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.29. The firm earned $76.26 million during the quarter, compared to the consensus estimate of $70.40 million. Tabula Rasa HealthCare had a positive return on equity of 3.63% and a negative net margin of 7.09%. Tabula Rasa HealthCare's quarterly revenue was up 56.9% on a year-over-year basis. During the same period last year, the business posted $0.20 EPS. View Tabula Rasa HealthCare's Earnings History.

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Tabula Rasa HealthCare.

Tabula Rasa HealthCare updated its third quarter 2019 earnings guidance on Thursday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.82 million.

8 equities research analysts have issued 1 year price targets for Tabula Rasa HealthCare's stock. Their predictions range from $58.00 to $99.00. On average, they anticipate Tabula Rasa HealthCare's share price to reach $79.04 in the next twelve months. This suggests a possible upside of 61.6% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating, 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

News articles about TRHC stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Tabula Rasa HealthCare.

Some companies that are related to Tabula Rasa HealthCare include Ritchie Bros. Auctioneers (RBA), TriNet Group (TNET), Healthequity (HQY), WNS (WNS), Envestnet (ENV), HMS (HMSY), Sothebys (BID), Farfetch (FTCH), EVO Payments (EVOP), ExlService (EXLS), Wageworks (WAGE), Cardtronics (CATM), Viad (VVI), Stamps.com (STMP) and CBIZ (CBZ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), Micron Technology (MU), Canopy Growth (CGC), Netflix (NFLX), salesforce.com (CRM), Advanced Micro Devices (AMD), GW Pharmaceuticals PLC- (GWPH), QUALCOMM (QCOM) and VMware (VMW).

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Tabula Rasa HealthCare's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Peregrine Capital Management LLC (1.38%), Artemis Investment Management LLP (1.00%), Summit Creek Advisors LLC (0.66%), Taylor Wealth Management Partners (0.53%), Envestnet Asset Management Inc. (0.11%) and State of Alaska Department of Revenue (0.07%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

TRHC stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC and Taylor Wealth Management Partners. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.

TRHC stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Artemis Investment Management LLP, Summit Creek Advisors LLC, HMS Capital Management LLC, Envestnet Asset Management Inc. and Nisa Investment Advisors LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TRHC stock can currently be purchased for approximately $48.92.

Tabula Rasa HealthCare has a market capitalization of $1.08 billion and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.View Additional Information About Tabula Rasa HealthCare.

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com/.

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]